Jurisch Daniel, Laufs Ulrich
Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, Liebigstraße 20, 04109, Leipzig, Deutschland.
Internist (Berl). 2021 Jan;62(1):47-57. doi: 10.1007/s00108-020-00910-0.
In 2019 the European Society for Cardiology (ESC) published guidelines for the diagnosis and management of chronic coronary syndromes (CCS). Thus the term "stable coronary artery disease" is replaced by CCS. The newly introduced term is based on the current understanding of pathogenesis and clinical features of coronary artery disease (CAD) as well as therapeutic management. CCS defines CAD as a chronic process that can be influenced by lifestyle adjustments, pharmacological therapies and invasive interventions (percutaneous coronary intervention, coronary artery bypass grafting) with the aim of stabilization or regression. The present work provides an overview of various scenarios that involve CCS and diagnostic pathways to clarify potentially relevant CAD. It also highlights therapeutic management and secondary preventive procedures in accordance with the current recommendations of the ESC.
2019年，欧洲心脏病学会（ESC）发布了慢性冠状动脉综合征（CCS）的诊断和管理指南。因此，“稳定型冠状动脉疾病”这一术语被CCS所取代。这个新引入的术语基于对冠状动脉疾病（CAD）发病机制、临床特征以及治疗管理的当前理解。CCS将CAD定义为一种慢性过程，可通过生活方式调整、药物治疗和侵入性干预（经皮冠状动脉介入治疗、冠状动脉旁路移植术）来影响，目的是实现病情稳定或逆转。本研究概述了涉及CCS的各种情况以及诊断途径，以阐明潜在相关的CAD。它还根据ESC的当前建议强调了治疗管理和二级预防措施。
